z-logo
Premium
Blood transfusion transmission of the tick‐borne relapsing fever spirochete B orrelia miyamotoi in mice
Author(s) -
Krause Peter J.,
Hendrickson Jeanne E.,
Steeves Tanner K.,
Fish Durland
Publication year - 2015
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/trf.12879
Subject(s) - relapsing fever , virology , biology , blood transfusion , transmission (telecommunications) , immunology , medicine , electrical engineering , engineering
Background B orrelia miyamotoi , a recently discovered relapsing fever spirochete, occurs in hard‐bodied ticks wherever L yme disease is endemic. Human infection is associated with relapsing fever and can cause meningoencephalitis in immunocompromised patients. A few cases of transfusion transmission of other relapsing fever spirochete species have been reported but none for B . miyamotoi . Our objective was to determine whether B . miyamotoi transfusion transmission could occur in a murine transfusion model. Herein, we report transfusion transmission of B . miyamotoi through fresh or stored red blood cells ( RBC s) in a mouse model. Study Design and Methods Inbred mice were transfused with B . miyamotoi –infected murine blood that was either freshly collected or stored for 7 days before transfusion. Recipient blood was then longitudinally examined after transfusion by smear and wet mount for evidence of spirochetemia. Results Motile spirochetes were observed in immunocompromised ( SCID ) mouse recipients for 28 days after transfusion of both fresh and stored murine B . miyamotoi –infected RBC s. Transient spirochetemia was observed in immunocompetent DBA /2 and C 57 BL /6 mice, with spirochete clearance occurring within 5 days after transfusion. Conclusion These data demonstrate that transfusion transmission of B . miyamotoi can occur in mice and suggest that it also may occur in humans.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here